Orthopedics, Postoperative Complications, Red Blood Cells
Conditions
Brief summary
The investigators sought to examine the effects of 'old' red blood cells on mortality and morbidity of patients who undergoing revision hip replacement arthroplasty. The investigators hypothesis is that patients have an increased risk of mortality and infection after 'old' red blood cells transfusions compared with those who received 'new' transfusions.
Interventions
PROCEDUREOld red blood cells transfusion
Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty)
PROCEDURENew red blood cells transfusion
Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty)
Sponsors
Seoul National University Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who underwent revision total hip replacement
Exclusion criteria
* Patients who were not given red blood cells * Patients who were given two units of which one unit was old and one was new
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality | postoperative 7 days |
| Sepsis | postoperative 7 days |
| Wound infection | postoperative 7 days |
| Postoperative delirium | postoperative 7 days |
| Postoperative bleeding | postoperative 7 days |
Secondary
| Measure | Time frame |
|---|---|
| Renal failure | postoperative 7 days |
| Transfusion related lung injury | postoperative 7 days |
| Hepatic failure | postoperative 7 days |
| Pulmonary edema | postoperative 7 days |
| Pulmonary effusion | postoperative 7 days |
| Myocardial ischemia | postoperative 7 days |
| Pulmonary thromboembolism | postoperative 7 days |
Countries
South Korea
Outcome results
None listed